ITC shares have advanced nearly 9 per cent in the last five sessions.

Now, will there be any form of dividend or some kind of repayment to the shareholders or they are going to plough it all into these various...

“The valuations are very attractive and therefore it is time to start looking at them but they are probably some time away before they can ...

Under-ownership, attractive valuations, strong outlook make pharma stocks a good buy, says CIO & MD Chakri Lokapriya.

98% of the listed universe is trading at discount to what is happening to ultra mega cap stocks.

TCG’s Nation Development Agenda (NDA 2.0) have been designed keeping expected NDA-2 policies in mind.

We continue to be overweight on SBI, Union Bank and all private sector banks, says Lokapriya

Market is telling us that political uncertainty is going to be less of an issue, says Lokapriya.

We may see some rebound in metals as and when the US trends up in the next day or two, says MD of TCG AMC.

“Even after correction, multiples are still not cheap enough to buy at the current level.”

"We see better earnings coming out in the ongoing quarter and management guiding to an improved outlook for subsequent quarters."

Within NBFCs, we are still sticking to housing, says Chakri Lokapriya, CIO & MD, TCG AMC.

Not sure whether we are closer to the lows or not and whether we will see a recovery anytime soon

“In pharmaceuticals, we do not see any upside from the current levels, rather we see more downside”

It is unlikely that you would make extra return on ONGC or HPCL because of this deal.

Consumers are realising that interest rates are not going low any further

Earnings wise, I do not think we will see an uptick anytime over the next year after GST. This is more a longer term thing